SOSEI GROUP
Sosei Group Corporation is an international biopharmaceutical company originating from Japan that discovers and develops innovative biopharmaceuticals for the treatment of Alzheimer's disease, schizophrenia, cancer, migraine, addiction, metabolic disease, and other indications. By utilizing their platform technologies - GPCR structure-based drug design platform technology, peptide platform technologies and nanotechnology - they have established a product pipeline with first/best in class potential. Through development and commercialization partnerships they have already delivered three medicines to the market (two COPD bronchodilators and an emergency contraceptive), which generate significant and stable revenue streams that enable further growth.
SOSEI GROUP
Social Links:
Industry:
Biopharma Biotechnology Medical
Founded:
1990-06-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.sosei.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
265.03 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS 1and1 Adobe Dreamweaver Sophos
Similar Organizations
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2015-02-22 | Heptares Therapeutics | Heptares Therapeutics acquired by Sosei Group | 400 M USD |
2005-07-19 | Arakis Limited | Arakis Limited acquired by Sosei Group | 106.5 M GBP |
Investors List
COVID-19 Therapeutics Accelerator
COVID-19 Therapeutics Accelerator investment in Grant - Sosei Group
JAFCO
JAFCO investment in Post-IPO Equity - Sosei Group
Scottish Equity Partners
Scottish Equity Partners investment in Post-IPO Equity - Sosei Group
Resona Capital
Resona Capital investment in Series B - Sosei Group
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Series B - Sosei Group
Mitsui Global Investment
Mitsui Global Investment investment in Series B - Sosei Group
JAFCO
JAFCO investment in Series B - Sosei Group
Japan Asia Investment
Japan Asia Investment investment in Series B - Sosei Group
Nomura Holdings
Nomura Holdings investment in Series B - Sosei Group
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2017-05-03 | MiNA Therapeutics | Sosei Group investment in Corporate Round - MiNA Therapeutics | 35 M GBP |
2016-11-11 | JITSUBO | Sosei Group investment in Venture Round - JITSUBO | 2.5 B JPY |
Official Site Inspections
http://www.sosei.com
- Host name: s20998836.onlinehome-server.info
- IP address: 217.160.183.146
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin